Generative Adversarial Networks in Digital Histopathology: Current Applications, Limitations, Ethical Considerations, and Future Directions.

artificial intelligence deep learning digital histopathology ethical considerations generative adversarial networks histopathology image segmentation

Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
27 Oct 2023
Historique:
received: 15 06 2023
revised: 04 10 2023
accepted: 19 10 2023
pubmed: 28 10 2023
medline: 28 10 2023
entrez: 27 10 2023
Statut: aheadofprint

Résumé

Generative adversarial networks (GANs) have gained significant attention in the field of image synthesis, particularly in computer vision. GANs consist of a generative model and a discriminative model trained in an adversarial setting to generate realistic and novel data. In the context of image synthesis, the generator produces synthetic images, whereas the discriminator determines their authenticity by comparing them with real examples. Through iterative training, the generator allows the creation of images that are indistinguishable from real ones, leading to high-quality image generation. Considering their success in computer vision, GANs hold great potential for medical diagnostic applications. In the medical field, GANs can generate images of rare diseases, aid in learning, and be used as visualization tools. GANs can leverage unlabeled medical images, which are large in size, numerous in quantity, and challenging to annotate manually. GANs have demonstrated remarkable capabilities in image synthesis and have the potential to significantly impact digital histopathology. This review article focuses on the emerging use of GANs in digital histopathology, examining their applications and potential challenges. Histopathology plays a crucial role in disease diagnosis, and GANs can contribute by generating realistic microscopic images. However, ethical considerations arise because of the reliance on synthetic or pseudogenerated images. Therefore, the manuscript also explores the current limitations and highlights the ethical considerations associated with the use of this technology. In conclusion, digital histopathology has seen an emerging use of GANs for image enhancement, such as color (stain) normalization, virtual staining, and ink/marker removal. GANs offer significant potential in transforming digital pathology when applied to specific and narrow tasks (preprocessing enhancements). Evaluating data quality, addressing biases, protecting privacy, ensuring accountability and transparency, and developing regulation are imperative to ensure the ethical application of GANs.

Identifiants

pubmed: 37890670
pii: S0893-3952(23)00274-0
doi: 10.1016/j.modpat.2023.100369
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100369

Informations de copyright

Copyright © 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Shahd A Alajaji (SA)

Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Baltimore, Maryland; Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia; Division of Artificial Intelligence Research, University of Maryland School of Dentistry, Baltimore, Maryland.

Zaid H Khoury (ZH)

Department of Oral Diagnostic Sciences and Research, School of Dentistry, Meharry Medical College, Nashville, Tennessee.

Mohamed Elgharib (M)

Max Planck Institute for Informatics, Saarbrucken, Germany.

Mamoon Saeed (M)

AstraZeneca, Gaithersburg, Maryland.

Ahmed R H Ahmed (ARH)

8708 Hugo CT, Columbia, Maryland.

Mohammad B Khan (MB)

8921 Alliston Hollow Way, Gaithersburg, Maryland.

Tiffany Tavares (T)

Department of Comprehensive Dentistry, UT Health San Antonio, School of Dentistry, San Antonio, Texas.

Maryam Jessri (M)

Oral Medicine and Pathology Department, School of Dentistry, University of Queensland, Herston, Queensland, Australia; Oral Medicine Department, Metro North Hospital and Health Services, Queensland Health, Queensland, Australia.

Adam C Puche (AC)

Department of Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland.

Hamid Hoorfar (H)

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.

Ivan Stojanov (I)

Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.

James J Sciubba (JJ)

Department of Otolaryngology, Head and Neck Surgery, The Johns Hopkins University, Baltimore, Maryland.

Ahmed S Sultan (AS)

Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Baltimore, Maryland; Division of Artificial Intelligence Research, University of Maryland School of Dentistry, Baltimore, Maryland; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland. Electronic address: asultan1@umaryland.edu.

Classifications MeSH